Multi-stage deep learning predicts hematocrit from CMR data, suggesting improved extracellular volume fraction assessment.
Motivation: Blood sampling for hematocrit (HCT) measurement limits clinical use of extracellular volume fraction (ECV) in diagnosing myocardial diseases. Goal(s): Develop and evaluate a deep learning (DL) model to predict HCT from cardiovascular magnetic resonance (CMR) data, exploring if additional features improve predictability across multiple centers. Approach: Trained a multi-stage DL model using multi-center CMR T1 values and clinical features to predict HCT without blood sampling. Results: The DL model identified native blood-pool T1 and gender as optimal features, achieving higher correlation with true HCT (R=0.65) than linear regression (R=0.59) and strong agreement between synthetic and true ECV (R=0.95). Impact: This study shows that incorporating additional features in a DL model enhances HCT prediction from CMR data, eliminating the need for blood sampling. This advancement could streamline ECV measurement, making it more accessible for diagnosing myocardial diseases in clinical settings.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: